Re: Phase III, Double-Blind, Randomized Trial that Compared Maintenance Lapatinib versus Placebo after First-Line Chemotherapy in Patients with Human Epidermal Growth Factor Receptor 1/2-Positive Metastatic Bladder Cancer. [electronic resource]

By: Producer: 20190508Description: 891-892 p. digitalISSN:
  • 1527-3792
Subject(s): Online resources: In: The Journal of urology vol. 199
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
No physical items for this record

Publication Type: Journal Article; Comment

There are no comments on this title.

to post a comment.